Centromere

Optimal result: 0 – 100 units/ml

Anti-centromere antibodies (ACA) are directed against centromere proteins. The serological detection of ACA is relevant for both diagnostics and differentiation. ACA can be found in 20% to 30% of SSc patients, most frequently in Caucasians. In most cases, ACA are associated with LSSc.

The presence of ACA, with a prevalence of 80% to 95%, is considered an indicator of a mild disease course and good prognosis. In DSSc, which also includes lung fibrosis, ACA are detected in around 8% of patients.

Furthermore, 15% to 30% of patients with primary biliary cirrhosis (PBC), which is also an autoimmune disease, express ACA. Antibodies against Disease Prevalence Centromeres Systemic sclerosis (Ssc) - limited form (LSSc) - diffuse form (DSSc) Primary biliary cirrhosis (PBC) 20% - 30% 80% - 95% approx. 8% 15% - 30%.

Centromere B Antibody is diagnostic for the form of scleroderma known as CREST (calcinosis, Raynaud's phenomenon, esophageal immotility, sclerodactyly, and telangiectasia).

With a high specificity and a prevalence of 80 to 95%, antibodies against centromeres are pathognomonic for the limited form of progressive systemic sclerosis and can be detected even before the onset of the disease. If the corresponding clinical indication is given, the quantitative determination of antibodies with a monospecific test system, e.g. the Anti-Centromeres ELISA, is recommended.

Anti-centromere antibodies (ACA) are directed against centromere proteins. The serological detection of ACA is relevant for both diagnostics and differentiation. ACA can be found in 20% to 30% of SSc patients, most frequently in Caucasians. In most cases, ACA are associated with LSSc.

The presence of ACA, with a prevalence of 80% to 95%, is considered an indicator of a mild disease course and good prognosis. In DSSc, which also includes lung fibrosis, ACA are detected in around 8% of patients.

Furthermore, 15% to 30% of patients with primary biliary cirrhosis (PBC), which is also an autoimmune disease, express ACA. Antibodies against Disease Prevalence Centromeres Systemic sclerosis (Ssc) - limited form (LSSc) - diffuse form (DSSc) Primary biliary cirrhosis (PBC) 20% - 30% 80% - 95% approx. 8% 15% - 30%.

--------------

Systemic sclerosis (SSc) is a chronic inflammatory autoimmune disease which occurs in phases and is characterised by accumulation of collagen in the skin and inner organs. Main symptoms of SSc include skin thickening and episodes of disturbed blood flow in the fingers (Raynaud's syndrome), particularly in cold weather or if the patient suffers from stress. SSc is further characterised by arthritic joint pains and symptoms in the gastrointestinal tract, lungs, heart, kidneys and other inner organs.

SSc is divided into:

- the diffuse form (DSSc),

- the limited form (LSSc)

- and PM/SSc or PM/SLE/SSc overlap syndrome.

DSSc affects the connective tissue of the lungs, kidneys, oesophagus and heart, with lung sclerosis being the most frequent cause of death. LSSc, which is equated to a large extent with CREST syndrome (calcinosis cutis, Raynaud's phenomenon, oesophagus motility disorder, sclerodactyly, teleangiectasis), affects the extremities rather than the inner organs. PM/SSc overlap syndrome is characterised by myositis, interstitial lung disease, arthritis, Raynaud's phenomenon, fever and hyperkeratosis of the hands.

Centromere
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Centromere — 10,000+ markers explained
One Centromere result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro